CytoPherx

About:

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Website: http://www.cytopherx.com

Top Investors: Kaiser Permanente Ventures, Aphelion Capital, ONSET Ventures, Capital Midwest Fund, Emergent Medical Partners

Description:

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.